Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BVS is expected to report earnings to rise 44.00% to 21 cents per share on August 11
Q2'26
Est.
$0.22
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.04
Q2'25
Est.
$0.21
The last earnings report on May 06 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 1.06M shares outstanding, the current market capitalization sits at 590.09M.